Qantas frequent flyer down 30% | Aussie med-tech accused by NYU of rip off | Allbirds announces 'first sustainable IPO'

Qantas Loyalty, which sells frequent flyer points to banks and retailers, has seen earnings drop 30% thanks to covid.   New York University (aka NYU) is accusing Aussie med-tech company ResMed of ripping off its sleep apnea product.   Allbirds, the Kiwi shoe and clothing company, is describing its upcoming IPO as the ‘first sustainable public equity offering’.   ---   Flux Daily Quiz: Win a $100 Uber Eats voucher: https://quiz.flux.finance/ Save money and win cash prizes up to $250k weekly: https://bit.ly/Wintheweek Get your credit score for free: https://bit.ly/fluxcreditscore Download the free app (App Store): http://bit.ly/FluxAppStore Download the free app (Google Play Store): http://bit.ly/FluxappGooglePlay Daily newsletter: https://bit.ly/fluxnewsletter Instagram: http://bit.ly/fluxinsta TikTok: https://www.tiktok.com/@flux.finance   ---   The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.See omnystudio.com/listener for privacy information.